PTC Therapeutics Inc (NASDAQ:PTCT)

Delayed Data
As of Jun 19
 -14.64 / -30.58%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 28.00, with a high estimate of 35.00 and a low estimate of 15.00. The median estimate represents a -15.76% decrease from the last price of 33.24.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 36.09%
Growthannually 45.12%


Growthquarterly 19.27%
Growthannually 40.63%
Key to the earnings and sales forecast charts.